De Novo Engineering of Metal–Organic Framework‐Printed In Vitro Diagnostic Devices for Specific Capture and Release of Tumor Cells
Source abstract
Abstract
Abstract Herein, a paper‐based in vitro diagnostic device (IVD) is developed via inkjet printing of de novo engineered, boronic acid‐rich metal–organic frameworks (BMOFs). The newly developed BMOFs simultaneously possess crystalline and amorphous structure, mesopore size, large surface area, and retain a high level of boronic acid integration. After printing the BMOFs on the filter paper, the BMOF‐printed paper IVD shows a rapid response time (40 min) towards cancer cell capture and its maximum cell capture capacity reaches approximately (4.5 ±1.1) ×104 cells cm−2. Furthermore, the BMOF‐printed IVD shows nine times higher capture ability of cancer cells than non‐cancerous cells, suggesting its excellent selectivity. Importantly, the pH‐tunable affinity of BMOF to glucose enables its dual‐responsive behavior without affecting cell viability. In addition, a desired cell pattern could be achieved by directly drawing BMOFs onto a silicon substrate, highlighting its capacity as a miniaturized device for tumor cell capture and analysis. This simple and label‐free nanoplatform enables new opportunities for designing MOF‐based smart devices for diverse biomedical applications such as a cost‐effective IVD technologies for cancer diagnosis, genotyping, and prognosis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemical Engineering and Australian Centre for NanoMedicine The University of New South Wales Sydney NSW 2052 Australia
Graduate School of Biomedical Engineering The University of New South Wales Sydney NSW 2052 Australia
X‐ray Diffraction Laboratory Mark Wainwright Analytical Centre The University of New South Wales Sydney NSW 2052 Australia
Funding
Australian Research Council
References (55)
Show source-provided references
1. 10.1038/s41571-020-00457-x10.1038/s41571-020-00457-x ↗
2. 10.1002/adma.20180534410.1002/adma.201805344 ↗
3. 10.1021/acsami.0c0335510.1021/acsami.0c03355 ↗
4. 10.1021/ac300563310.1021/ac3005633 ↗
5. 10.1039/C4TB00456F10.1039/C4TB00456F ↗
6. 10.1039/C4LC00136B10.1039/C4LC00136B ↗
7. 10.1039/B917959C10.1039/B917959C ↗
8. 10.1073/pnas.151398811210.1073/pnas.1513988112 ↗
9. 10.1002/ange.20100585310.1002/ange.201005853 ↗
10. 10.1002/adma.20140380710.1002/adma.201403807 ↗
11. 10.1002/adma.20160164310.1002/adma.201601643 ↗
12. 10.1021/ja401000m10.1021/ja401000m ↗
13. 10.1002/adfm.20150242010.1002/adfm.201502420 ↗
14. 10.1021/acs.chemmater.8b0164610.1021/acs.chemmater.8b01646 ↗
15. 10.1016/j.apmt.2017.12.00910.1016/j.apmt.2017.12.009 ↗
16. 10.1002/adfm.20200023810.1002/adfm.202000238 ↗
17. 10.1038/ncomms824010.1038/ncomms8240 ↗
18. 10.1002/ange.20201400210.1002/ange.202014002 ↗
19. 10.1016/j.nantod.2021.10125610.1016/j.nantod.2021.101256 ↗
20. 10.1021/acs.est.0c0468810.1021/acs.est.0c04688 ↗
21. 10.1002/anie.20201009310.1002/anie.202010093 ↗
22. 10.1016/j.chempr.2019.10.01210.1016/j.chempr.2019.10.012 ↗
23. 10.1002/adfm.20200164810.1002/adfm.202001648 ↗
24. 10.1002/tcr.20200006710.1002/tcr.202000067 ↗
25. 10.1039/C9SC02021G10.1039/C9SC02021G ↗
26. 10.1002/adfm.20170212610.1002/adfm.201702126 ↗
27. 10.1039/C6NR08071E10.1039/C6NR08071E ↗
28. 10.1016/j.bios.2017.04.02110.1016/j.bios.2017.04.021 ↗
29. 10.1021/acs.inorgchem.8b0224010.1021/acs.inorgchem.8b02240 ↗
30. 10.1016/j.cej.2018.02.00110.1016/j.cej.2018.02.001 ↗
31. 10.1039/C9TB00361D10.1039/C9TB00361D ↗
32. 10.1039/C8NJ05318A10.1039/C8NJ05318A ↗
33. 10.1021/acs.analchem.9b0541010.1021/acs.analchem.9b05410 ↗
34. 10.1021/acssuschemeng.9b0429310.1021/acssuschemeng.9b04293 ↗
35. 10.1021/acssuschemeng.8b0617110.1021/acssuschemeng.8b06171 ↗
36. 10.1016/j.chroma.2018.02.01310.1016/j.chroma.2018.02.013 ↗
37. 10.1021/jacs.9b1163910.1021/jacs.9b11639 ↗
38. 10.1038/s41467-019-13153-x10.1038/s41467-019-13153-x ↗
39. 10.1016/j.bios.2020.11209510.1016/j.bios.2020.112095 ↗
40. 10.1021/acsnano.5b0309710.1021/acsnano.5b03097 ↗
41. 10.1021/acscatal.7b0169610.1021/acscatal.7b01696 ↗
42. 10.1002/cctc.20190029810.1002/cctc.201900298 ↗
43. 10.1016/j.chempr.2019.03.02510.1016/j.chempr.2019.03.025 ↗
44. 10.1021/acs.jpcc.5b0952010.1021/acs.jpcc.5b09520 ↗
45. 10.1016/j.heliyon.2019.e0122210.1016/j.heliyon.2019.e01222 ↗
46. 10.1016/j.saa.2017.05.06810.1016/j.saa.2017.05.068 ↗
47. 10.1007/BF0263431710.1007/BF02634317 ↗
48. 10.1002/ange.20180480210.1002/ange.201804802 ↗
49. 10.1016/j.matpr.2021.01.76110.1016/j.matpr.2021.01.761 ↗
50. Geary S. J. · Isr. Med. Assoc. J. · 1987 · 23 · 462
51. 10.1016/j.snb.2011.07.02310.1016/j.snb.2011.07.023 ↗
52. 10.1021/cr200027j10.1021/cr200027j ↗
53. Ma Y. · Research · 2021 · 2021
54. 10.1186/s40643-017-0171-710.1186/s40643-017-0171-7 ↗
55. 10.1002/adma.20150316710.1002/adma.201503167 ↗